Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
70 studies found for:    Blood Transfusion | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
Blood Transfusion | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Transfusion of Prematures Trial
Conditions: Infant, Newborn, Diseases;   Infant, Extremely Low Birth Weight;   Infant, Small for Gestational Age;   Bronchopulmonary Dysplasia (BPD);   Anemia
Interventions: Procedure: Liberal Cell Transfusion;   Procedure: Restricted red cell transfusion
2 Recruiting PICU Transfusion Study: Harmful Effects of Red Blood Cell Transfusions
Condition: Iron, Abnormal Blood Level
Interventions: Biological: Transfusion of red blood cells;   Biological: Infusion of albumin/saline
3 Unknown  Frozen Red Blood Cell Transfusions in Trauma Patients
Condition: Transfusion
Intervention: Biological: Red Blood Cells
4 Recruiting Does Plasma Reduce Bleeding in Patients Undergoing Invasive Procedures
Conditions: Blood Coagulation Disorders;   Hemorrhage
Intervention: Biological: Fresh frozen plasma transfusion
5 Recruiting Australian and New Zealand Massive Transfusion Registry
Conditions: Massive Transfusion;   Trauma;   Cardiothoracic Surgery;   Gastrointestinal Bleeding;   Vascular Surgery;   Obstetric Bleeding;   Liver Transplant
6 Recruiting Study of Transfusion-Transmitted Infections
Condition: Virus Disease
7 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells
8 Not yet recruiting Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Conditions: Anemia;   Myelodysplastic Syndrome
Interventions: Drug: Deferasirox;   Other: Laboratory Biomarker Analysis
9 Recruiting RBC Irradiation, Anemia and Gut Injury
Conditions: Anemia;   Necrotizing Enterocolitis
Intervention: Device: Near Infrared Spectroscopy
10 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
11 Recruiting Improving White Blood Cell Collection From Healthy Donors
Conditions: Blood Donor;   Leukocyte Transfusion;   Granulocyte Colony-Stimulation Factor;   Blood Component Removal
Interventions: Drug: Filgrastim (G-CSF);   Drug: Dexamethasone
12 Recruiting Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
Conditions: Zika Virus;   Dengue Virus;   Chikungunya Virus Infections
13 Unknown  Simplified Severe Sepsis Protocol-2 (SSSP-2) in Zambia
Conditions: Sepsis;   Severe Sepsis;   Tuberculosis
Interventions: Other: Simplified severe sepsis protocol;   Other: Usual care
14 Recruiting AVERT Shock: Arginine Vasopressin During the Early Resuscitation of Traumatic Shock
Condition: Traumatic Shock
Intervention: Drug: Vasopressin
15 Unknown  Simplified Severe Sepsis Protocol in Zambia
Conditions: Sepsis;   Severe Sepsis
Intervention: Other: Simplified Severe Sepsis Protocol
16 Recruiting Establishment of a Perinatal Database and a Bank of Biological Materials
Conditions: Preterm Labor;   Preterm Birth;   Pregnancy
17 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment;   Unilineage Bone Marrow Failure Disorders
Intervention: Drug: Eltrombopag
18 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
19 Recruiting Massive Iron Deposit Assessment
Conditions: Iron Overload;   Excessive Body Iron Burden
Interventions: Device: R2*-UTE;   Device: R2*-GRE;   Procedure: Liver biopsy
20 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist, Eltrombopag, in Patients With Low to Int-2 Risk Myelodysplastic Syndrome (MDS)
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Intervention: Drug: Eltrombopag

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years